Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lialda vs Asacol in Ulcerative Colitis Maintenance
NCT00151892Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2005
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 28
01
Overview
Phase 3, randomised, double-blind trial of Salcrozine in ulcerative colitis (UC) (2 arms), sponsored by Takeda. Primary endpoint: Endoscopic Remission of Ulcerative Colitis (UC) at 6 Months. Started Apr 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00151892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151892.